HomepageBlogEvonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine Blog Industry Evonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine admin Posted on August 14, 2023 Evonik Industries AG supplies lipids essential to production of the Pfizer–BioNTech COVID-19 vaccine, in which messenger RNA (mRNA) is enclosed…… Please subscribe to read the full story. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Post navigation Next PostChemical Innovation: Unveiling the Dynamics of Japan’s Thriving Chemical Industry You Might Also Like Blog High Market Prices for MMA Continue to Hold Strong admin August 14, 2023 Blog JSR Pursues New Developments in Life Sciences Business admin August 14, 2023 Blog Ajinomoto Works on Sustainability in Thailand admin August 14, 2023 Blog Rion Targets Regenerative Medicine Facilities for Particle Counter Sales admin August 14, 2023